1.
早期NSCLC患者接受SBRT治疗总结
Reports of NSCLC patients receiving SBRT treatment
| Author | Published time | Research type | Number of cases | Mean follow-up time (mo) | Primary tumor and local control rate | 3-year OS (%) | 3-year PFS (%) |
| OS: overall survival; PFS: progression-free survival; SBRT: stereotactic body radiation therapy; NSCLC: non-small cell lung cancer. | |||||||
| Baumann P[3] | 2009 | Polycentric, Prospective | 57 | 36 | 92% (3-year) | 60 | 52 |
| Timmerman R[4] | 2010 | Polycentric, Prospective | 55 | 34.4 | 90.6% (3-year) | 55.8 | 48.3 |
| Haasbeek CJ[5] | 2011 | Retrospective | 37 (Lung mun), 26 (pericardium) |
35 | 92.6% (Lung mun), 90.2% (pericardium) |
64.3 | / |
| Chang JY[6] | 2015 | Prospective | 58 | 40.2 | / | 95 | 86 |